Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.61
Delayed Data
As of Jul 31
 +0.28 / +2.27%
Today’s Change
9.51
Today|||52-Week Range
17.53
-18.65%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.33
Today’s open12.35
Day’s range12.19 - 12.83
Volume915,760
Average volume (3 months)1,667,462
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-27.55%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio62.8
Price/Sales9.80
Price/Book46.52

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.31+3.95%
DBVTDBV Technologies SA+0.63+1.47%
FGENFibroGen Inc+0.33+1.44%
EXELExelixis Inc+0.19+3.43%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts